Press Releases

NEW YORK, Dec. 4 /PRNewswire/ -- For its highly anticipated holiday show, the New Vic welcomes back long-time favorites The Flaming Idiots in the new Chestnuts Roasting on The Flaming Idiots, which will run at The New Victory from December 4, 2009, through January 3, 2010.

Chestnuts Roasting on The Flaming Idiots represents a happy and unexpected reunion for the madcap comedians, who performed what was supposed to be their "very last show ever" at The New Victory in 2004. But lucky for New York audiences the hiatus is over! In this buffoonery-filled neo-vaudevillian variety show, Gyro, Pyro and Walter bring some of their signature acts back to the New Vic -- beanbag chair juggling, balloon swallowing, and flaming torch juggling -- along with a goody bag full of zany new antics.

Performance Schedule

Fri -- 12/4 -- 7pm
Sat -- 12/5 -- 2pm, 7pm
Fri -- 12/11 -- 7pm*
Sat -- 12/12 -- 2pm, 7 pm
Sun -- 12/13 -- 12pm, 5pm#
Fri -- 12/18 -- 7pm
Sat -- 12/19 -- 2pm, 7pm
Sun -- 12/20 -- 12pm, 5pm
Wed -- 12/23 -- 2pm, 7pm
Thu -- 12/24 -- 2pm
Sat -- 12/26 -- 2pm, 7pm
Sun -- 12/27 -- 12pm, 5pm
Tue -- 12/29 -- 2pm
Wed -- 12/30 -- 2pm, 7pm
Thu -- 12/31 -- 2pm
Sat -- 1/2 -- 2pm, 7pm
Sun -- 1/3 -- 12pm, 5pm

*indicates sign-interpreted performance. # indicates Talk-back following the performance.

Ticket Information

Holiday show tickets for members cost $35 (orchestra), $21 (mezzanine) and $10.50 (balcony). Tickets for non-members cost $50 (orchestra), $30 (mezzanine) and $15 (balcony).

On sale now

    --  ONLINE at NewVictory.org
    --  BY PHONE at 646-223-3010; Monday-Friday 12 noon-8 pm; Saturday 10 am-8
        pm; Sunday 10 am-5 pm
    --  IN PERSON at The New Victory Theater Box Office; Box office hours:
        Sunday & Monday 11 am-5 pm; Tuesday-Saturday 12 noon-7 pm

About The Flaming Idiots

The Flaming Idiots are a comedy juggling trio featuring Jon O'Connor, Rob Williams and Kevin Hunt -- otherwise known as Pyro, Gyro and Walter. The Flaming Idiots gained popularity in the 1980s by street performing and traveling the renaissance faire circuit. In 2000, they replaced the renaissance-related theme of their show with a neo-vaudeville motif, basing their performances on juggling and object manipulation with an emphasis on comedy. They became known for such signature routines as juggling beanbag chairs, balloon swallowing, escaping from intertwined straight jackets, and juggling with flaming torches and knives. Gyro, in particular, became known for his uncanny ability to assemble a bologna sandwich with his feet -- a trick which landed him in the Guinness Book of World Records and an appearance on "The Tonight Show with Jay Leno."

CONTACTS:
Laura Kaplow-Goldman (646) 223-3065
Allison Mui (646) 223-3067

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE The New 42nd Street, Inc.

TAMPA, Fla., Dec. 4 /PRNewswire/ -- The Bible has been translated into almost 400 languages. Easy enough, right? But what is not so easy to translate is the often confusing and misleading nuisances contained within the literal text of the world's best-selling book. "The Cross Trap" author Elmer H. Haygood is wise enough to know that you don't take up the task of enlightening the reader in a book-by-book or verse-by-verse approach. Such an undertaking would require multiple volumes and a 24/7 writing regiment! Instead he goes for the "heart and soul" of the Bible's greatest story - the Crucifixion.

"The Cross Trap" (published by iUniverse) builds a case for the formidable and near-infallible plot to make Jesus unworthy in the eyes of God through careful examination of often overlooked circumstances, exposing a well-conceived conspiracy to send Jesus back to face his maker as a shameful sinner. While the scriptures remain the spurious cornerstone to the religious leaders' opposition to Jesus as an authoritative teacher, their most grave omission was a total misunderstanding or disbelief of Jesus' primary role as the savior. Yet Satan's cause de force was maligning Jesus as the perfect sacrificial Lamb of God for the remission of sin and destroying his sanctity as a symbolic sacrifice. Haygood takes on a multitude of questions concerning the ministry of Christ as well as his crucifixion. For example, "Why would the religious leaders allow Jesus to teach daily in the synagogue if they considered him a false teacher, blasphemer, and sorcerer?" or "Why was Jesus' cry of desperation 'My God, my God, why have you forsaken me?" - a seemingly blatant contradiction to his acceptance of God's will? In addition, "why were two thieves chosen to die with Jesus?" A saga that goes down to the wire, Haygood writes with clarity and sensitivity as he separates myth from magic, fact from fiction, and faith from fantasy.

About the Author

Elmer M. Haygood graduated from Hardin-Simmons University, a nationally recognized Christian liberal arts college in Abilene, Texas. A native of Greensboro, North Carolina, Haygood has engaged the new generation of believers in matter-of-fact and in-depth discussions concerning both the literal and symbolic meanings of the Scriptures. As a consequence of his youth-oriented Bible study programs within the Church of God in Christ, young people have actively engaged in reflective research and candid questioning of God's word. His working life outside the church has focused primarily on social services within the community. "The Cross Trap: A Layman's Theory" is Haygood's first book.

"The Cross Trap: A Layman's Theory"

Available from: http://www.iUniverse.com, http://www.bn.com, and http://www.amazon.com

iUniverse is the premier book publisher for emerging, self-published authors. For more information, please visit http://www.iuniverse.com.

EDITORS: For review copies or interview requests, contact:

Promotional Services Department
Tel: 1-800-AUTHORS
Fax: 812-355-4078
Email: promotions@iuniverse.com
(When requesting a review copy, please provide a street address.)

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE iUniverse

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/20b4f4/south_africa_minin) has announced the addition of the "South Africa Mining Report Q1 2009" report to their offering.

This South Africa Mining Report provides industry professionals and strategists, corporate analysts, mining associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on South Africa's mining industry

The combined effects of the global economic crisis, plummeting commodity prices and an earlier power crisis have greatly impacted the South African mining sector. The downturn has prompted many mining companies to scale back operations, cut proposed exploration and development projects and lay off workers. The Financial Times reported in January 2009 that up to 14,000 workers in the industry are facing redundancy. However, some firms are weathering the slowdown better than others, with iron ore producers in particular benefiting from a strong market driven by China's high demand.

Accounting for nearly one-third of South Africa's total exports, mining is a vital industry for the country's economy. South Africa hosts the world's largest deposits of gold and about 80% of the global platinum reserves. It is also a significant producer of diamonds. But the country's mining industry is observed to have matured and the pace of mineral exploration has fallen over the years, and even more so in recent months as firms reduce capital expenditure and scale back projects.

Major closures have taken place in the chromium and manganese sectors, with multiple furnaces shut down as demand slumped, as well as in the uranium sector. South African gold production continued to decline, with a massive 14% drop in output in 2008, reported to be largely due to ongoing power rationing and labour unrest. Diamond production also fell, but De Beers successfully opened its Voorspoed mine. A crash in platinum prices in late 2008 impacted producers heavily, and two major takeover bids by South African Impala Platinum and Swiss Xstrata were abandoned. Coal exports fell in 2008 and some firms announced cuts of capital expenditure, but growth drivers for 2009 could include increased demand from the state-owned power company, Eskom, and modernisation of transportation links. Iron ore production was largely sustained by high demand from China, and some iron ore producers pressed ahead with development projects.

Significant job cuts have been announced by firms including Lonmin, DRDGOLD and Uranium One,and are being mooted by companies such as Anglo Platinum, Gold Fields, Simmer and Jack Mines, Petra Diamonds, Rockwell Diamonds and De Beers.

As previously reported, the South African government has revived a dormant state company to start buying up assets within the mining sector. The African Exploration, Finance and Mining Corporation will reportedly receive funding of ZAR180mn for three years of exploration. The CEO Sizwe Madondo told Mining Weekly Online that the Corporation was pursuing coal and uranium opportunities. But the government to faced criticism in October 2008 over proposed exemptions for the company from requirements imposed on private firms, including applying for mining rights. Reuters reported that the Chamber of Mines, representing mining firms in South Africa, had expressed concern over the exemptions. The Department of Minerals and Energy tried to downplay the concerns, with spokesman Bheki Khumalo saying that the company would only be 'required to inform the DME of its mining interest rather than formally apply.'

Industry Forecast BMI forecasts that South Africa's mining sector will reach a value of US$20.16bn in 2013. However, how long the country can continue its relatively strong performance is yet to be seen. In the short term we expect growth to slow due to the impact of the financial crisis on global commodity prices, which is forcing producers to scale back production. Meanwhile, reserves are depleting, which is slowing the rate of expansion, while power shortages and labour unrest are also disrupting the sector, Still, the sheer size of the mining industry, representing 5.2% of South Africa's GDP in 2008, should ensure that the industry remains resilient. The country is also likely to be among the first to benefit when the global economy returns to strength.

Key Topics Covered:

Executive Summary

Industry Trends And Developments

    --  Overview
    --  Latest Developments
    --  Regulatory Structure
    --  Latest Developments

Key Projects

    --  Metals
    --  Chromium
    --  Iron Ore
    --  Gold
    --  Manganese
    --  Nickel
    --  Platinum
    --  Uranium
    --  Minerals
    --  Coal
    --  Diamonds

Business Environment

    --  Regional Overview - Africa
    --  Limits To Potential Returns
    --  Risks To Realisation Of Returns
    --  Legal Framework
    --  Labour Force
    --  Foreign Investment Policy

Political Environment

    --  Industry Forecast Scenario
    --  Metals Price Outlook
    --  Global Industry Overview
    --  Regional Analysis
    --  South Africa Mining Industry Forecast
    --  Competitive Landscape

Company Monitor

    --  Lonmin
    --  Anglo American
    --  BHP Billiton
    --  African Rainbow Minerals (ARM)

For more information visit http://www.researchandmarkets.com/research/20b4f4/south_africa_minin

    Source: Research and Markets

Clinical Data will Cover Treatments from the Earliest Pre-Symptomatic Stages to Long-Term Disease Control with Good Quality of Life

Studies in Myeloma Lead to Treatments for Several Types of Blood Cancers

Data to be Presented at the 2009 Meeting of the American Society of Hematology (ASH)

NORTH HOLLYWOOD, Calif.--(BUSINESS WIRE)-- The International Myeloma Foundation (IMF)--supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians--today said presentations at the annual meeting of the American Society of Hematology (ASH) will cover all stages of multiple myeloma, a major milestone in treating this and related cancers. Studies will cover treating the disease from smoldering (early) myeloma before clinical symptoms occur, to long-term continuous therapy, and onto promising new regimens for patients who no longer respond to existing drugs. The studies will be presented at the ASH annual meeting, December 5 through 8 in New Orleans.

"In recent years we have seen the life expectancy of many patients doubled with the novel therapies, REVLIMID(R), VELCADE(R) and THALOMID(R), and now the next generation of drugs under development, including pomalidomide and carfilzomib, gives us an opportunity to extend survival even further," said Susie Novis, president and co-founder of the IMF. "We are seeing the novel therapies and combinations of all of these drugs evaluated in every possible setting: newly diagnosed, long-term care with and without stem cell transplants, elderly and younger patients. We look forward to promising presentations at ASH that point to the possibility of helping patients live longer and live better."

Among the areas highlighted by the IMF:

    --  Treating patients before they show any symptoms is controversial, but
        from Spain a study of REVLIMID in what's called smoldering myeloma is an
        important first step toward reconsidering how patients are treated at
        the earliest stages of this cancer. (abstract #614)
    --  At the other end of the myeloma continuum, studies are expected to show
        promising results with continuous REVLIMID treatment through to disease
        progression, and maintenance therapies using VELCADE, and VELCADE with
        THALOMID in various patient populations. (#3, #128, #613)
    --  For patients who have run out of options there will be studies of the
        newest drugs in the development pipeline including pomalidomide,
        carfilzomib and vorinostat. The results are expected to show patients
        will respond to drugs such as pomalidomide even when they no longer
        respond to other drugs in the same class. (#301-#306, #429, #430)

Brian G.M. Durie, M.D., chairman and co-founder of the IMF said, "We have come a long way in treating multiple myeloma, but a study from the IMF's International Myeloma Working Group looks at what happens when patients no longer respond to the available treatments. This makes a powerful case for continuing innovation in treatment development, while it gives us a benchmark we can use to evaluate new drugs as they come along." (#2878)

Other highlights at ASH include:

Multiple myeloma setting the stage for new treatments for a range of cancers: REVLIMID, developed for use in myeloma and also approved for use in myelodysplastic syndromes or MDS, is now the subject of Phase III studies in a variety of cancers including diffuse large B-cell lymphoma, chronic lymphocytic leukemia, and pivotal studies in mantle cell lymphoma. (#206, #944, #1676, #1679) Likewise VELCADE is approved in mantle cell lymphoma and is also the subject of Phase II studies in follicular lymphoma that will be presented at ASH. (#933, #1661)

Scientific underpinnings of side effects and predicting outcome from the International Myeloma Working Group and the IMF gene back, Bank On A Cure(R): One of the studies suggests a combination of chromosome abnormalities coupled with stage of the disease is a better predictor of outcome when evaluated together than either factor alone. (#743) A second study finds specific genetic changes may be responsible for side effects of treatment such as neuropathy, making it possible to build a data base that anticipates adverse events. (#1800)

Multiple myeloma is a cancer of cells in the bone marrow that affects production of blood cells and can damage bone. Myeloma affects an estimated 750,000 people worldwide, and in industrialized countries it is being diagnosed in growing numbers and in increasingly younger people.

ABOUT THE INTERNATIONAL MYELOMA FOUNDATION

The International Myeloma Foundation is the oldest and largest myeloma organization, reaching more than 195,000 members in 113 countries worldwide. A 501 (c) 3 non-profit organization dedicated to improving the quality of life of myeloma patients and their families, the IMF focuses in four key areas: research, education, support, and advocacy. To date, the IMF has conducted more than 200 educational seminars worldwide, maintains a world-renowned hotline, and operates Bank on a Cure(R), a unique gene bank to advance myeloma research. The IMF can be reached at (800) 452-CURE. The global Website is www.myeloma.org.

    Source: The International Myeloma Foundation

DALLAS, Dec. 4, 2009 (GLOBE NEWSWIRE) -- InvestorSoup.com announces an investment report featuring Sigma Designs Inc. (Nasdaq: SIGM). The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

It is available at: http://www.investorsoup.com/lp/SIGM

Get our alerts BEFORE the rest of the market. Follow us on Twitter: www.twitter.com/investorsoup

Sigma Designs Inc. (SIGM) is a fabless provider of integrated system-on-chip (SoC), solutions that are used to deliver multimedia entertainment throughout the home. The Company offers four distinct technologies that the Company markets as separate product lines: media processors, VXP video image processing, Ultra-wideband devices and Z-wave devices. Each of these technologies also contributes to its fully integrated SoC offerings. Its SoC solutions combine its semiconductors and software and are a component of multiple high-growth, consumer applications that process digital video and audio content, including Internet protocol television (IPTV), connected media player, high definition televisions (HDTVs), and portable media players.

Message Board Search for SIGM: http://www.boardcentral.com/boards/SIGM

In the report, the analyst notes:

"Net revenue for the third quarter was $35.5 million, a decrease of $15.8 million, or 31%, from $51.3 million reported in the previous quarter and down $11.3 million, or 24%, from $46.8 million reported for the same period last year.

"SIGM in mid-November announced the completion of its acquisition of CopperGate Communications Ltd. Under the terms of the acquisition agreement, which was previously announced on October 13, 2009, SIGM has acquired all of the outstanding share capital of CopperGate for a cash payment of approximately $116 million and the issuance to CopperGate shareholders of an aggregate of approximately 3.9 million shares of SIGM common stock."

To read the entire report visit: http://www.investorsoup.com/lp/SIGM

See what investors say about these stocks at: http://www.stockhideout.com/

InvestorSoup.com is a small-cap research and investment commentary provider. InvestorSoup.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on InvestorSoup.com, please visit http://www.InvestorSoup.com

InvestorSoup.com Disclosure

InvestorSoup.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. InvestorSoup.com is a Web site wholly owned by BlueWave Advisors, LLC. Please read our report and visit our Web site, InvestorSoup.com, for complete risks and disclosures.

CONTACT: InvestorSoup.com
         Jeffrey Brown, Editor
         (469)-252-3505
         info@investorsoup.com